ecancer

ecancer.org

ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.

 

ecancer
G

ESMO GI 2024 Insights: Paclitaxel and Ramucirumab in HER2- Advanced GC/GEJC - Ph3 ARMANI Trial

By ecancer FEATURING Giovanni Randon
By ecancer FEATURING Giovanni Randon
41 views
July 29, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

19:05
Deciphera

Patient Case Discussion on a Treatment Approach for Advanced Gastroi…

Feat. M. Agulnik

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
GI Cancers
05:11

ESMO GI 2024 Insights: Paclitaxel and Ramucirumab in HER2- Advanced …

ecancer

G. Randon

41 views
05:13

ESMO GI 2024 Insights: Impact of Systemic Chemotherapy on Survival i…

ecancer

G. Bregni

81 views
05:19

Targeting BRAF V600E in mCRC: Where Are We Today?

ecancer

R. Motta Guerrero

84 views
08:33

Effectiveness and Tolerability of Cetuximab With XELOX or XELIRI in …

ecancer

J. Zekri

15 views
07:28

Durable Effect of Imatinib & Metronomic Chemo With Capecitabine in P…

ecancer

S. Al-Sukhun

13 views
06:31

CheckMate 649 Trial Biomarker Analyses of Nivo + Ipi vs. Chemo for P…

ecancer

Y. Y. Janjigian

231 views
04:43

Initial Results From a Phase 1 GLIMMER-01 Trial: Efficacy of Dose Es…

ecancer

J. Luke

75 views
07:45

Latest Treatments in Esophageal Cancer

ecancer

C. Bizekis

90 views
04:11

CRYSTAL Trial: Left vs. Right Sided GI Tumor Response

ecancer

E. Van Cutsem

148 views
10:08

ESMO GI 2022 on CRC: Impact of BRAF-V600E Mutation on Tumor Microenv…

ecancer

M. Salem

159 views
04:46

ESMO GI 2022 Update on MOUNTAINEER Trial: Tucatinib in Combination W…

ecancer

J. Strickler

65 views
04:53

Optimum Treatment Strategy Algorithm for mCRC

ecancer

H. Lenz

410 views
05:41

An Overview of Treatment Advances in Gastric Cancer

ecancer

D. Ilson

327 views
16:00

Tumor Agnostic Treatments in GI Cancers: Liquid Bipsy, Biomarkers

ecancer

N. Normanno, K. Schmitz

10 views
07:48

Tremelimumab and Durvalumab as 1L in Unresectable HCC: Phase 3 HIMAL…

ecancer

G. Abou-Alfa

257 views
06:19

Early Treatment Discontinuation and Early Oxaliplatin Discontinuatio…

ecancer

C. Gallois

79 views
06:04

ASCO GI 2022: OS With Durvalumab + Chemo in Advanced Biliary Tract C…

ecancer

D. Oh

135 views
04:06

ESMO 2021 Updates on Adagrasib +/- Cetuximab for CRC Patients Harbor…

ecancer

J. Weiss

65 views
09:04

2L Yttrium-90 Radioembolization With Chemo for CRC Liver Metastases

ecancer

M. Mulcahy

31 views
05:16

ESMO 2021 Data on Anti-TIGIT Antibody Tiragolumab + Atezolizumab in …

ecancer

Z. Wainberg

388 views
05:39

ESMO 2021 Update on BRAFV600E mCRC: cfDNA BRAF Mutant Allele Fractio…

ecancer

E. Elez

34 views
07:19

ESMO 2021 Data on 1L Bevacizumab in CRC With BRAF Mutation: BEACON C…

ecancer

D. Aderka

62 views
05:54

2020 ESMO Updates on GI Cancers: 1L Nivo + Chemo in Advanced GC/GEJC…

ecancer

B. Gyawali

39 views
08:16

2020 ESMO Update on CheckMate 577: Does Nivolumab Demonstrate DFS Im…

ecancer

R. Kelly

157 views
06:26

2020 ESMO Update on CheckMate 459: What Are the OS Outcomes With 1L …

ecancer

B. Sangro

87 views
08:38

2020 ESMO Update on 1L Non-HER2+ Advanced GC/GEJ/EC: Will Nivolumab …

ecancer

M. Moehler

119 views